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Abstract In this study we show that Reg1, the regulatory sub-
unit of the Reg1/Glc7 protein phosphatase (PP1) complex, in-
teracts physically with the two yeast members of the 14-3-3
protein family, Bmh1 and Bmh2. By using di¡erent fragments
of the Reg1 protein we mapped the interaction domain at the
N-terminal part of the protein. We also show that Reg1 and
yeast 14-3-3 proteins participate actively in the regulation of the
glucose-induced degradation of maltose permease (Mal61).
- 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The yeast Saccharomyces cerevisiae regulates metabolism,
gene expression and growth in response to carbon source
availability. In the presence of glucose, the most preferred
carbon source, yeast induces transcriptionally the expression
of several genes such as those encoding glycolytic enzymes,
ribosomal proteins and some glucose transporters (see [1] for
review). At the same time, glucose represses at the level of
transcription the expression of a large number of genes, in-
cluding those involved in the utilization of alternative carbon
sources, gluconeogenesis and respiration by a process known
as glucose repression (see [2,3] for review). Glucose is also
able to induce a rapid loss of activity of the enzymes of the
gluconeogenic pathway (e.g. fructose 1,6-bisphosphatase) and
of several sugar transporters (the high-a⁄nity glucose trans-
porter, galactose permease and maltose permease) and stim-
ulate an increase in the rate of degradation of these proteins
by a process known as catabolite inactivation [4^10].
In general, the regulation of the di¡erent nutrient signaling
pathways is achieved by the modulation of the activity of
speci¢c protein kinases and phosphatases. For example,
GLC7, an essential gene that encodes the catalytic subunit
of the yeast protein phosphatase type 1 (PP1) [11], is involved
in the regulation of glucose repression, glycogen metabolism
and translation initiation, among other processes (see [12] for
review), and participates in the regulation of these pathways
by binding to speci¢c regulatory subunits that target the phos-
phatase to the corresponding substrates. Reg1 (Hex2) is one
of these regulatory subunits and targets Glc7 to substrates
involved in the glucose repression pathway [13,14]. In fact,
it is known that the Reg1/Glc7 phosphatase complex is in-
volved in the regulation of the activity of the Snf1 kinase
complex, a crucial player in the glucose repression pathway
[15,16]. In addition, the Reg1/Glc7 phosphatase complex is
also involved in the transduction of the glucose signal in the
process of catabolite inactivation [17].
In order to identify additional components that could help
Reg1 in performing its functions, we carried out a two-hybrid
screening using LexA-Reg1 as bait. As a result of this screen-
ing we identi¢ed Bmh1 and Bmh2, the S. cerevisiae members
of the 14-3-3 protein family. In this yeast, 14-3-3 proteins
participate in the regulation of di¡erent crucial physiological
processes such as exocytosis and vesicle transport, RAS/
MAPK (mitogen-activated protein kinase) signalling cascade
during pseudohyphal development, regulation of the subcellu-
lar localization of Msn2/4 [transcriptional activators of STRE
(stress response element)-regulated genes], regulation of rapa-
mycin-sensitive signalling (through the TOR kinase pathway)
and proteasome-regulated protein degradation (see [18,19], for
review).
In this study we also demonstrate that yeast 14-3-3 proteins
participate, in addition, in the process of catabolite inactiva-
tion of maltose permease. We suggest that 14-3-3 proteins
a¡ect this pathway because they bind to the Reg1/Glc7 phos-
phatase complex, an already known regulator of this process
[17].
2. Materials and methods
2.1. Strains and genetic methods
S. cerevisiae strain FY250 (MATK his3v200 leu2v1 trp1v63 ura3-
52) was a gift from Dr. F. Winston (Harvard Medical School, Boston,
MA, USA). Strain FY250 reg1v : :URA3 was described in [16]. Strains
41278 (MATK his3 leu2 trp1 ura3-52) and 41278 bmh1vbmh2v were
from Dr. G. Fink (Whitehead Institute for Medical Research, MIT,
Cambridge, MA, USA) [20]. Strains ENY.WA-1A (MATK ura3-52
leu2-3,112 trp1-289 his3-v1) and ENY.hex2-3A (reg1) (MATa
leu2-3,112 ura3-52 hex2-3) were from Dr. Karl-Dieter Entian (Institut
fu«r Mikrobiologie, Johann Wolfgang Goethe-Universita«t, Frankfurt,
Germany) [21]. Strains CTY10-5d (MATa ade2 his3 leu2 trp1 gal4
gal80 URA3: :lexAop-lacZ) and TAT-7 (MATa ade2 his3 leu2 trp1
gal4 gal80 LYS2: :lexAop-HIS3 URA3: :lexAop-lacZ) were a gift
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from Dr. R. Sternglanz (State University of New York, Stony Brook,
NY, USA).
Standard methods for genetic analysis and transformation were
used. Yeast cultures were grown in synthetic complete (SC) medium
lacking appropriate supplements to maintain selection for plasmids
[22], supplemented with di¡erent carbon sources.
2.2. Oligonucleotides
The oligonucleotides used were BMH2-1 (318)CCGGGATCCC
AAAAAAAAATGTCCCAAACTC, BMH2-2 (+843) CCCCTCGAG
TTTGTCGACGCTCTTATTTGGTTGG, REG1-1 (39)GCCGAAT
TCATGTCAACAAATCTAGCAAATTACTTC, REG1-198 (+1503)-
CCATGGGATCCATGAGGCATTTTCTAAC, REG1-120 (+1260)-
CGTCATCTAGATCATCATCTGAAGAATTG- CTT. The number
in parentheses corresponds to the ¢rst base of the oligonucleotide with
respect to (+1)ATG. New restriction sites are underlined.
2.3. Plasmids
To construct pBTM-Reg1 (LexA-Reg1; TRP1 as selection marker),
an EcoRI/SalI fragment from plasmid pRJ65 (LexA-Reg1, HIS3 [23])
was subcloned into pBTM116 [24]. To construct pLexA-Reg1(1^313),
an EcoRI/BamHI fragment from plasmid pSB27 (LexA-Reg1(1^443)
[16]) was subcloned into pEG202 [25]. To construct pLexA-Reg1-
(1^198), oligonucleotides REG1-1 and REG1-198 (see above) were
used to amplify by polymerase chain reaction (PCR) a fragment of
the REG1 gene using pSB27 as template; the ampli¢ed fragment was
digested with EcoRI and BamHI and subcloned in pEG202. To con-
struct pLexA-Reg1(1-120), oligonucleotides REG1-1 and REG1-120
(see above) were used as before; the ampli¢ed fragment was digested
with EcoRI and XbaI and subcloned in pUC18; then, an EcoRI/SalI
fragment was subcloned in pEG202.
To construct pEG-Bmh2 (LexA-Bmh2), oligonucleotides BMH2-1
and BMH2-2 (see above) were used to amplify by PCR the BMH2
gene from genomic DNA of FY250. The ampli¢ed fragment was
digested with BamHI and XhoI and subcloned in pEG202. The
same fragment was introduced in pACTII [26] and pGST [27], to
obtain pACTII-Bmh2 (Gal4 activating domain [GAD]-Bmh2) and
pGST-Bmh2 (glutathione S-transferase [GST]-Bmh2), respectively.
To construct YEpACT-hemagglutinin epitope (HA)-Glc7, a frag-
ment from pHA-Glc7 [23] was introduced in the YEpACT vector [28].
Other plasmids used in this study were pRJ55 (LexA-Snf1), pRJ57
(LexA-Snf4) and pRJ65 (LexA-Reg1) [29]; pSB55 [GAD-Reg1(3^
1014)], pSB52 [GAD-Reg1(3^760)], pSB32 [GAD-Reg1(3^485)],
pSB31 [GAD-Reg1(3^447)], pSB27 [LexA-Reg1(1^443)], pBF414
[GAD-Reg1(424^1014)] and pSB17 (pSK-Reg1, HA-Reg1) [16]. Plas-
mid pSO74 (ADH1p-HXT1) was described in [30]; plasmids YCp50-
MAL63 and pRS315-MAL61-HA were described in [17].
2.4. Two-hybrid screening
A two-hybrid screening [31] for proteins that interacted with LexA-
Reg1 (pBTM-Reg1, see above) was carried out in strain TAT-7 (see
above). The strain was transformed with a library of S. cerevisiae
cDNAs fused to GAD [32]. Transformants were selected in SC+2%
glucose plates and were subsequently screened for L-galactosidase
activity using a ¢lter lift assay [33].
2.5. Invertase and L-galactosidase assays
Invertase activity was assayed in whole cells as previously described
[29]. L-Galactosidase activity was assayed in permeabilized cells and
expressed in Miller units as in [15].
2.6. Preparation of cell extracts by the fast boiling method
Cells corresponding to 1 U A600 were collected by rapid centrifu-
gation (14 000 rpm, 1 min), resuspended in 100 Wl of Laemmli sample
bu¡er [34] and boiled for 3 min. Glass beads (0.3 g, 450 Wm diameter)
were added to the suspension and then cells were vortexed at full
speed for 30 s. The suspension was boiled again for 3 min and cen-
trifuged at 14 000 rpm for 1 min. 20 Wl of the supernatant was sub-
jected to sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and immunoblotting.
2.7. Pull-down assay
Preparation of protein extracts and pull-down assays were essen-
tially as described previously [16].
2.8. Immunoblot analysis
Protein samples were separated by SDS^PAGE and analyzed by
immunoblotting using the corresponding antibodies: anti-GST
(Amersham), anti-Hxk2 polyclonal antibodies [21] or anti-HA (Boehr-
inger Mannheim) monoclonal antibodies. Antibodies were detected by
enhanced chemiluminescence with ECL or ECL Plus reagents (Amer-
sham).
3. Results and discussion
3.1. Reg1 interacts with members of the yeast 14-3-3 protein
family, Bmh1 and Bmh2
Reg1 (a regulatory subunit of the PP1 protein phosphatase
Fig. 1. Bmh2 interacts with the N-terminal domain of Reg1. A: Reg1 sequences fused to either GAD or LexA that were used in the two-hy-
brid analysis. None of these fusions showed detectable self-activating activity. B: CTY10-5d transformants expressing the indicated pair of pro-
teins were grown exponentially in 4% glucose medium; all the GAD fusions were based on plasmid pACTII except for GAD-Reg1(424^1014)
that was based on pACT; all the LexA fusions were based on plasmid pEG202. Values are average L-galactosidase activities of four to six
transformants, with standard deviation lower than 15% in all cases. Protein levels of interacting proteins were similar in all cases (not shown).
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complex) is involved in both the regulation of the glucose
repression pathway and the transduction of the glucose signal
that regulates the process of catabolite inactivation. In order
to identify additional components that could help Reg1 in
performing its functions, we carried out a two-hybrid screen-
ing using LexA-Reg1 as bait (see Section 2). After screening
106 transformants, we recovered 12 positive transformants
that grew in the absence of histidine and were blue in the
L-galactosidase ¢lter assay. Inserts contained in these 12 plas-
mids were sequenced and the identity of the corresponding
genes determined by BLAST analysis [35]. Three inserts cor-
responded to in frame C-terminal fragments of the SSB1 and
SSB2 genes, members of the heat shock protein HSP70 family
[36]. Eight inserts corresponded to in frame cDNAs of the
BMH1 gene that started at di¡erent positions either at the
5P untranslated region or in the coding region. Finally, one
insert corresponded to an in frame fusion to 53 nucleotides
upstream of the starting ATG of the BMH2 gene. Since the
clones containing BMH1 and BMH2 were the most abundant,
we focused our attention on their interaction with Reg1. Our
results were in agreement with those recently reported in
which the interaction between Reg1 and Bmh1 was con¢rmed
by a⁄nity precipitation [37].
Bmh1 and Bmh2 are the yeast members of the 14-3-3 pro-
tein family (see [18] for review). Reg1 was able to interact with
both Bmh1 and Bmh2 proteins, although the interaction was
better with Bmh2. As is shown in Table 1, pACT-Bmh1-
(clone16) (an in frame fusion of GAD to ¢ve nucleotides up-
stream of the starting ATG of BMH1) showed lower interac-
tion values than pACT-Bmh2(clone10) (an in frame fusion
of GAD to 53 nucleotides upstream of the starting ATG
of BMH2). Since the interaction between LexA-Reg1 and
Bmh2 was stronger than in the case of Bmh1 (see Table 1),
and since it has been described that Bmh2, although being
produced in lower amounts than Bmh1, was more active
[38], we focused our attention on the Bmh2 protein. Using
synthetic oligonucleotides we ampli¢ed by PCR the coding
region of BMH2, which was sequenced to con¢rm that no
modi¢cations had been introduced by the Taq polymerase.
This fragment was used to construct LexA-Bmh2 and GAD-
Bmh2 derivatives that were used to study the domains of the
Reg1 protein involved in their interaction (Fig. 1). We ob-
served that Bmh2 interacted only with the N-terminal part
of Reg1 (residues 1^313) (Western blot analysis indicated
that the interacting proteins were produced at similar levels
in all cases; data not shown). This Bmh2 interaction domain
was independent of the motif of interaction with Glc7
(RHIHF468ND), located more towards the middle of the pro-
tein [16].
The physical interaction between Bmh2 and Reg1 was con-
¢rmed by pull-down assays. Using a GST-Bmh2 fusion pro-
tein we observed a speci¢c interaction between Bmh2 and
Reg1 (Fig. 2, compare lanes 2, 4 and 5). If in the reg1v cells
expressing GST-Bmh2 and HA-Reg1 we additionally overex-
pressed HA-Glc7 (the catalytic subunit of the Reg1/Glc7
phosphatase complex), we observed that GST-Bmh2 was
also able to pull down HA-Glc7 (Fig. 2, lane 1), but this
was dependent on the presence of Reg1 (Fig. 2, lane 3). These
results indicate that GST-Bmh2 was able to interact physically
with the Reg1/Glc7 phosphatase complex in glucose growing
cells. We repeated the pull-down assay in cells that had been
shifted to carbon starvation conditions for 10, 30 and 60 min
and observed that the binding between GST-Bmh2 and the
Reg1/Glc7 phosphatase complex remained after the shift (data
not shown).
Fig. 2. Bmh2 interacts physically with Reg1 and Glc7. Protein ex-
tracts (250 Wg) were prepared from FY250 reg1v : :URA3 glucose
growing cells expressing GST-Bmh2 (pGST-Bmh2), HA-Reg1 (pSK-
Reg1) and HA-Glc7 (YEpACT-HA-Glc7) or the corresponding
empty vectors pGST, pSK93 and YEpACT. GST-Bmh2 fusion pro-
teins were pulled down with glutathione-agarose. Pelleted proteins
were analyzed by SDS^PAGE and immunodetected with anti-HA
monoclonal antibodies (upper panel). Proteins in the input crude ex-
tracts (5 Wg) were also immunodetected with either anti-HA (middle
panel) or anti-GST (lower panel). Additional bands observed in
lanes with HA-Reg1 were degradation products. The position of a
protein in the crude extracts that cross-reacts non-speci¢cally with
anti-HA is indicated with an asterisk. Size standards are indicated
in kDa.
Table 1
Reg1 interacts with Bmh1 and Bmh2
L-Galactosidase (U)
LexA-Reg1 pACT-Bmh1(16) 217
LexA-Reg1 pACT-Bmh2(10) 314
LexA-Reg1 pACT 6 1
LexA pACT-Bmh2(10) 6 1
Two-hybrid interaction between pBTM-Reg1 (LexA-Reg1) and dif-
ferent clones recovered after the two-hybrid screening was measured
in TAT-7 cells. Values for cells growing exponentially in 4% glucose
are average L-galactosidase activities of four to six transformants,
with standard deviation lower than 15% in all cases.
FEBS 27301 21-5-03
I. Mayordomo et al./FEBS Letters 544 (2003) 160^164162
3.2. Yeast 14-3-3 proteins are not involved in the regulation of
the glucose repression pathway
Since the Reg1/Glc7 protein phosphatase complex is in-
volved in the regulation of the glucose repression pathway
(see Section 1), we checked for possible interactions between
Bmh2 and other components of this pathway. However, LexA
fusions to Snf1, Snf4 (Snf1 activator subunit), and Hxk2 (Snf1
negative regulator) did not show any positive interaction with
GAD-Bmh2, in either high or low glucose conditions (data
not shown). To analyze the possible involvement of Bmh2 in
the process of glucose repression we studied the regulation of
SUC2 expression, a gene encoding the enzyme invertase
whose expression is repressed by glucose [2], in a double
bmh1vbmh2v mutant. It is known that a double bmh1vbmh2v
mutation is lethal in most yeast genetic backgrounds but it is
still viable in the 41278b background [20]. Using mutants in
this background we observed that regulation of SUC2 expres-
sion was not a¡ected in the absence of 14-3-3 proteins (data
not shown). We also overexpressed Bmh2 and found that
regulation of SUC2 expression was not a¡ected either (data
not shown). Therefore, yeast 14-3-3 proteins were not in-
volved in the regulation of the glucose repression pathway.
3.3. Yeast 14-3-3 proteins are involved in the regulation of the
catabolite inactivation pathway of maltose permease
(Mal61)
It has recently been described that the Reg1/Glc7 phospha-
tase complex plays an additional role in the transduction of
the glucose signal in the process of catabolite inactivation
[10,17]). In the absence of Reg1, there was a signi¢cant reduc-
tion in the rate of glucose-induced proteolysis of maltose per-
mease (see [17] and Fig. 3A). To analyze if the yeast 14-3-3
proteins also a¡ected this pathway, we checked the glucose-
induced degradation of maltose permease in double
bmh1vbmh2v mutants and found a signi¢cant reduction in
the rate of degradation of maltose permease, similar to that
found in reg1v mutants (Fig. 3B). The only di¡erence was
that the amount of HA-Mal61 in the reg1v mutant appeared
to increase 3 h after the addition of glucose, but it decreased
signi¢cantly in the bmh1vbmh2v mutants, although this may
indicate that in the reg1v mutant, new synthesis of HA-Mal61
may proceed in the presence of a mixture of glucose and
maltose, since reg1v is also a glucose repression mutant, while
this process is blocked in the bmh1vbmh2v mutant. To rule
out the possibility that the reduction in the degradation rate
of Mal61 was due to a de¢cient glucose uptake in the double
mutant, we transformed these cells with a plasmid containing
the HXT1 low a⁄nity glucose transporter gene under the
control of the ADH1 gene promoter (plasmid pS074 [30]).
The process of glucose-induced degradation of maltose per-
mease was still signi¢cantly reduced in these cells (data not
shown). In addition, and as we have already mentioned be-
fore, the regulation of SUC2 expression was as in wild type,
indicating that glucose uptake was not severely a¡ected in the
double mutants. Therefore, we suggest that yeast 14-3-3 pro-
teins Bmh1 and Bmh2 participate actively in the transduction
of the glucose signal in the process of catabolite inactivation
of maltose permease, and that they might do so by binding to
the Reg1/Glc7 phosphatase complex, an already known regu-
lator of this process. Since 14-3-3 proteins a¡ect a great vari-
ety of physiological pathways [18], we cannot rule out the
possibility that 14-3-3 proteins a¡ect, in addition, other steps
in the regulation of glucose-induced degradation of maltose
permease, independent of Reg1/Glc7.
We tried to extend our results to the regulation of the
glucose-induced degradation of fructose 1,6-bisphosphatase
(Fbp1) and galactose permease (Gal2). However, for un-
known reasons, we were unable to detect these proteins in
the double bmh1vbmh2v mutants growing in glucose-contain-
ing media and shifted for to up to 16 h to media containing
either 2% glycerol or 2% galactose. The lack of expression of
galactose permease could be the reason why these double
bmh1vbmh2v mutants were unable to grow in galactose as
the only carbon source [20].
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